Hong Kong has the potential to become a global data centre hub, but uncertainties such as geopolitical concerns and fears over cross-border data transfer are holding back growth, according to industry observers.
Yuan Yuan, MD, PhD, discusses the OptimICE-pCR trial and other ongoing clinical trials in breast cancer being conducted at Cedars-Sinai, and expands on the role of CDK4/6 inhibitors and other novel treatment strategies for patients with hormone receptor-positive breast cancer.